Alivus Life Sciences Key Metrics

BSE: 543322 | NSE: ALIVUS | ISIN: INE03Q201024 | Sector: Biotechnology & Drugs

985.25 -14.75 (-1.48%)Updated : 17 Apr 2025

Ratios

Return on average equity - 5 year average	30.83
Net Income/employee - trailing 12 month	21,93,123.00
Revenue/employee - most recent fiscal year	1,18,97,940.00
Return on investment - most recent fiscal year	20.40
Return on average assets - most recent fiscal year	16.96
Receivables turnover - most recent fiscal year	2.90
Return on investment - trailing 12 month	0.00
Return on average assets - trailing 12 month	0.00
Inventory turnover - most recent fiscal year	1.54
Inventory turnover - trailing 12 month	0.00
Revenue/employee - trailing 12 month	1,12,90,650.00
Return on average assets - 5 year average	18.28
Net Income/employee - most recent fiscal year	24,53,820.00
Return on average equity - trailing 12 month	0.00
Receivables turnover - trailing 12 month	0.00
Asset turnover - most recent fiscal year	0.82
Asset turnover - trailing 12 month	0.00
Return on average equity - most recent fiscal year	21.07
Return on investment - 5 year average	29.99